Delapril/manidipine

Drug Profile

Delapril/manidipine

Alternative Names: Bimade; CHF 1521; Esprit (delapril/manidipine); Hipertil; Manidipine/delapril; Vivace

Latest Information Update: 23 Mar 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Takeda
  • Developer Chiesi
  • Class Antihypertensives; Dihydropyridines; Indans
  • Mechanism of Action ACE inhibitors; Calcium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Hypertension

Most Recent Events

  • 20 Oct 2003 A study has been added to the adverse events and Hypertension therapeutic trials sections
  • 09 Jan 2002 Registered for Hypertension in Italy (Unknown route)
  • 02 Sep 1999 Phase-III clinical trials for Hypertension in Italy (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top